Download - Cylophosphamide in Neuropsychiatric Sle
![Page 1: Cylophosphamide in Neuropsychiatric Sle](https://reader036.vdokumen.com/reader036/viewer/2022082610/55cf8f50550346703b9b1337/html5/thumbnails/1.jpg)
CYLOPHOSPHAMIDE IN NEUROPSYCHIATRIC SLE
![Page 2: Cylophosphamide in Neuropsychiatric Sle](https://reader036.vdokumen.com/reader036/viewer/2022082610/55cf8f50550346703b9b1337/html5/thumbnails/2.jpg)
ALGORITMA PENATALAKSANAAN SLE
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
![Page 3: Cylophosphamide in Neuropsychiatric Sle](https://reader036.vdokumen.com/reader036/viewer/2022082610/55cf8f50550346703b9b1337/html5/thumbnails/3.jpg)
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
![Page 4: Cylophosphamide in Neuropsychiatric Sle](https://reader036.vdokumen.com/reader036/viewer/2022082610/55cf8f50550346703b9b1337/html5/thumbnails/4.jpg)
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
![Page 5: Cylophosphamide in Neuropsychiatric Sle](https://reader036.vdokumen.com/reader036/viewer/2022082610/55cf8f50550346703b9b1337/html5/thumbnails/5.jpg)
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
![Page 6: Cylophosphamide in Neuropsychiatric Sle](https://reader036.vdokumen.com/reader036/viewer/2022082610/55cf8f50550346703b9b1337/html5/thumbnails/6.jpg)
Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia
![Page 7: Cylophosphamide in Neuropsychiatric Sle](https://reader036.vdokumen.com/reader036/viewer/2022082610/55cf8f50550346703b9b1337/html5/thumbnails/7.jpg)
– Cyclophosphamide given as monthly intravenous (500–1000mg/m2) doses for a six
month induction period followed by quarterly maintenance doses for a period of
two years
– Cyclophosphamide is a cytotoxic immunosuppressive treatment option with
documented therapeutic benefits in the management of severe NPSLE manifestations
unresponsive to other treatment modalities (nephritis and CNS manifestations)
Muscal, E & Brey, RL. 2011. Neurological Manifestations of Systemic Lupus Erythematosus in Children and Adults. NIH Public Access. Published in final edited form as:Neurol Clin. 2010 February
![Page 8: Cylophosphamide in Neuropsychiatric Sle](https://reader036.vdokumen.com/reader036/viewer/2022082610/55cf8f50550346703b9b1337/html5/thumbnails/8.jpg)
DAPUS
• Muscal, E & Brey, RL. 2011. Neurological Manifestations of Systemic Lupus Erythematosus in Children and Adults. NIH Public Access. Published in final edited form as: Neurol Clin. 2010 February
• Perhimpunan Rheumatologi Indonesia, 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Rekomendasi Perhimpunan Rheumatologi Indonesia